Edward J. Wos

632 total citations
10 papers, 500 citations indexed

About

Edward J. Wos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Edward J. Wos has authored 10 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Edward J. Wos's work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pain Mechanisms and Treatments (2 papers). Edward J. Wos is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pain Mechanisms and Treatments (2 papers). Edward J. Wos collaborates with scholars based in United States and Netherlands. Edward J. Wos's co-authors include Charles L. Loprinzi, Rui Qin, Bassam Mattar, Debra L. Barton, Kendrith M. Rowland, John W. Kugler, Bradley J. Christensen, Jeff A. Sloan, Pavan S. Reddy and Keith S. Lanier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Gynecologic Oncology.

In The Last Decade

Edward J. Wos

10 papers receiving 483 citations

Peers

Edward J. Wos
Celia M. Bridges United States
Lise Eckhoff Denmark
Kathleen Flynn United States
Grace Kanzawa-Lee United States
A Maestri Italy
Emmilia A. Dowlatshahi Netherlands
Hans Helge Bartsch Germany
Alice Fong United States
Aaron Galaznik United States
Jeanie F. Woodruff United States
Celia M. Bridges United States
Edward J. Wos
Citations per year, relative to Edward J. Wos Edward J. Wos (= 1×) peers Celia M. Bridges

Countries citing papers authored by Edward J. Wos

Since Specialization
Citations

This map shows the geographic impact of Edward J. Wos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Wos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Wos more than expected).

Fields of papers citing papers by Edward J. Wos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Wos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Wos. The network helps show where Edward J. Wos may publish in the future.

Co-authorship network of co-authors of Edward J. Wos

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Wos. A scholar is included among the top collaborators of Edward J. Wos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Wos. Edward J. Wos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jatoi, Aminah, Jorge J. Nieva, Rui Qin, et al.. (2012). A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites. Oncology. 82(6). 315–320. 14 indexed citations
2.
Watkins, John M., et al.. (2012). Synchronous presentation of advanced rectal and intermediate-risk prostate cancers: a multidisciplinary approach. Community Oncology. 9(2). 67–72. 2 indexed citations
3.
4.
Barton, Debra L., Edward J. Wos, Rui Qin, et al.. (2010). A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive Care in Cancer. 19(6). 833–841. 195 indexed citations
5.
Barton, Debra L., Edward J. Wos, Rui Qin, et al.. (2009). A randomized controlled trial evaluating a topical treatment for chemotherapy-induced neuropathy: NCCTG trial N06CA. Journal of Clinical Oncology. 27(15_suppl). 9531–9531. 4 indexed citations
6.
Johnson, Elizabeth A., Randolph S. Marks, Sumithra J. Mandrekar, et al.. (2007). Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer. 60(2). 200–207. 57 indexed citations
7.
Molina, Julian R., Daniel A. Nikcevich, Shauna L. Hillman, et al.. (2006). A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer. Cancer Investigation. 24(4). 382–389. 3 indexed citations
8.
9.
Clark, Matthew M., R. Douglas Hurt, Ivana T. Croghan, et al.. (2005). The prevalence of weight concerns in a smoking abstinence clinical trial. Addictive Behaviors. 31(7). 1144–1152. 99 indexed citations
10.
Wos, Edward J., Thomas Olencki, Laurie Tuason, et al.. (1996). Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma. Cancer. 77(6). 1149–1153. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celia M. Bridges Breakdown of academic impact, for papers by Lise Eckhoff Breakdown of academic impact, for papers by Kathleen Flynn Breakdown of academic impact, for papers by Grace Kanzawa-Lee Breakdown of academic impact, for papers by A Maestri Breakdown of academic impact, for papers by Emmilia A. Dowlatshahi Breakdown of academic impact, for papers by Hans Helge Bartsch Breakdown of academic impact, for papers by Alice Fong Breakdown of academic impact, for papers by Aaron Galaznik Breakdown of academic impact, for papers by Jeanie F. Woodruff
Rankless by CCL
2026